Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Precision proteogenomics reveals pan-cancer impact of germline variants

Cell(2025)10.1016/j.cell.2025.03.026Source: DataRank Database

Precision proteogenomics reveals pan-cancer impact of germline variants is a research paper published in Cell (2025). On theSindex it has a DataRank of 0.341. It has been cited 8 times, with 8 citing works in its 1-hop citation network.

N/A

0.341DataRank · unranked

Scored on demand from live citation data

Open Access8 citations · 8 citing works in its network

Download PDF

Cite:

Linked data & code

refsnp dbgap uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (32 grants)Impact (FWCI 4.07)OA: hybridTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (5)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 97%Citation Network 3%

Base Score Contribution

0.330

From this paper's citation signal

Citation Network Contribution

0.0112

From 3 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 8 citers.

The Primary Role of Noncoding RNA in the Pathogenesis of Cancer
Genes20251 citations92 referencesContributes 0.008
Bridging Realms: Artificial Intelligence Integrates Omics, Generative Models, and Traditional Medicine for Anticancer Drug Innovation
Journal of Pharmaceutical Analysis20261 citations211 referencesContributes 0.003
The Main Cancer Theories in Focus
20251 citations294 referencesContributes 0.002
Characterization of phosphorylation variants for identifying adaptive alleles in Zea
The Plant Journal20250 citations146 referencesContributes 0.000
Nuevas fronteras en la oncología de precisión: la transcriptómica y la proteómica
Revista Colombiana de Hematología y Oncología20260 citations54 referencesContributes 0.000

Authors (137)

Nadezhda V. Terekhanova ORCID,Kathleen J. Imbach ORCID,Karl R. Clauser ORCID,Myvizhi Esai Selvan ORCID,Isabel Mendizabal ORCID

Live enrichment

PubMed:40233739 PMC:PMC12326532 OpenAlex:https://openalex.org/W4409412615

Ministerio de Ciencia e Innovación

Grant: PID2019-107043RA-I00

Ministerio de Ciencia e Innovación

Grant: RYC2020-030632-I

Ministerio de Ciencia e Innovación

Grant: PID2019-108244RA-I00

Ministerio de Ciencia e Innovación

Grant: RYC2019-026415-I

National Institutes of Health

Grant: HHSN261201500003I

National Institutes of Health

Grant: HHSN26100064

NCI NIH HHS

Grant: U01 CA214116

NCI NIH HHS

Grant: U24 CA210972

NCI NIH HHS

Grant: R35 CA197588

NCI NIH HHS

Grant: U24 CA271012

NCI NIH HHS

Grant: U24 CA271114

NCI NIH HHS

Grant: R33 CA263705

NIGMS NIH HHS

Grant: R35 GM138113

NCI NIH HHS

Grant: HHSN261201500003C

NCI NIH HHS

Grant: U24 CA210986

NCI NIH HHS

Grant: U24 CA211006

NCI NIH HHS

Grant: U24 CA270823

NCI NIH HHS

Grant: U24 CA271075

NIH HHS

Grant: S10 OD030463

NCI NIH HHS

Grant: U01 CA214114

NCI NIH HHS

Grant: U24 CA210967

NCI NIH HHS

Grant: U24 CA210985

NCI NIH HHS

Grant: R35 CA253183

NCI NIH HHS

Grant: U01 CA214125

NCI NIH HHS

Grant: U24 CA210955

NCI NIH HHS

Grant: U24 CA210979

NCI NIH HHS

Grant: U24 CA210993

NHGRI NIH HHS

Grant: R01 HG009711

NCI NIH HHS

Grant: U24 CA210954

National Human Genome Research Institute

National Institutes of Health National Cancer Institute

U.S. Department of Health and Human Services

FWCI

4.07

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.cell.2025.03.026

publisherhttps://doi.org/10.1016/j.cell.2025.03.026

publisherhttps://api.elsevier.com/content/article/PII:S0092867425003447?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867425003447?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40233739

Fields of Study

Cancer Genomics and DiagnosticsCancer-related Molecular PathwaysEpigenetics and DNA Methylation

MeSH Terms

ProteogenomicsHumansNeoplasmsProtein Processing, Post-TranslationalGerm-Line MutationReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesProteomePolymorphism, Single NucleotideQuantitative Trait LociGenome-Wide Association Study

Keywords

BiologyProteogenomicsGermlineGeneticsComputational biologyCancerGermline mutationEvolutionary biologyGenomeGenomicsMutationGenePan-cancerCptacPrecision Peptidomics

Sustainable Development Goals

SDG 0: Zero hunger

Precision proteogenomics reveals pan-cancer impact of germline variants

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (137)

Funding (32 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)